Kenvue Inc. (NYSE:KVUE) Shares Purchased by Park Avenue Securities LLC

Park Avenue Securities LLC boosted its holdings in Kenvue Inc. (NYSE:KVUE) by 14.1% in the first quarter, HoldingsChannel.com reports. The firm owned 264,991 shares of the company’s stock after acquiring an additional 32,709 shares during the period. Park Avenue Securities LLC’s holdings in Kenvue were worth $6,354,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently added to or reduced their stakes in the company. SRS Capital Advisors Inc. boosted its holdings in Kenvue by 67.4% in the fourth quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company’s stock worth $30,000 after purchasing an additional 571 shares during the period. Asset Planning Inc acquired a new position in Kenvue in the fourth quarter worth $42,000. Clarity Asset Management Inc. acquired a new position in Kenvue in the fourth quarter worth $45,000. SBI Securities Co. Ltd. acquired a new position in shares of Kenvue during the fourth quarter valued at $46,000. Finally, Deseret Mutual Benefit Administrators boosted its holdings in shares of Kenvue by 29.0% during the fourth quarter. Deseret Mutual Benefit Administrators now owns 2,528 shares of the company’s stock valued at $54,000 after acquiring an additional 568 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Kenvue Stock Performance

KVUE stock opened at $21.73 on Monday. The company has a market capitalization of $41.69 billion, a P/E ratio of 41.00, a PEG ratio of 2.62 and a beta of 0.98. The company has a 50-day simple moving average of $23.12 and a 200 day simple moving average of $22.58. Kenvue Inc. has a fifty-two week low of $17.67 and a fifty-two week high of $25.17. The company has a quick ratio of 0.69, a current ratio of 1.00 and a debt-to-equity ratio of 0.66.

Kenvue (NYSE:KVUE) last posted its quarterly earnings data on Thursday, May 8th. The company reported $0.24 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.01. The business had revenue of $3.74 billion during the quarter, compared to the consensus estimate of $3.69 billion. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. The company’s quarterly revenue was down 3.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.28 earnings per share. Sell-side analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, May 28th. Shareholders of record on Wednesday, May 14th were given a $0.205 dividend. This represents a $0.82 annualized dividend and a yield of 3.77%. The ex-dividend date of this dividend was Wednesday, May 14th. Kenvue’s dividend payout ratio (DPR) is presently 149.09%.

Wall Street Analyst Weigh In

KVUE has been the subject of several analyst reports. Barclays boosted their price target on shares of Kenvue from $22.00 to $23.00 and gave the company an “equal weight” rating in a report on Monday, May 12th. UBS Group boosted their price target on shares of Kenvue from $24.00 to $25.00 and gave the company a “neutral” rating in a report on Friday, May 9th. Piper Sandler boosted their price target on shares of Kenvue from $24.00 to $27.00 and gave the company an “overweight” rating in a report on Monday, February 24th. Redburn Atlantic initiated coverage on shares of Kenvue in a report on Thursday, April 10th. They set a “neutral” rating and a $23.50 price target for the company. Finally, Evercore ISI initiated coverage on shares of Kenvue in a report on Monday, March 24th. They set an “in-line” rating and a $25.00 price target for the company. Seven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $25.33.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.